Precigen (PGEN) Depreciation & Amortization (CF) (2012 - 2026)

Precigen's (PGEN) quarterly Depreciation & Amortization (CF) came in at $1.1 million in Q1 2026, up 74.72% year-on-year from $629000.0 in Q1 2025, and down 3.34% on a QoQ basis from $1.1 million in Q4 2025.

Precigen (PGEN) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 15 years of Depreciation & Amortization (CF) data on file, last reported at $1.1 million in Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 74.72% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $3.7 million, a 3.06% increase from a year earlier, with the FY2025 full-year figure at $3.2 million, down 29.32% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $1.1 million, down from $1.1 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for PGEN reached as high as $3.3 million in Q1 2022 and fell as low as $629000.0 in Q1 2025.
  • Historically, Depreciation & Amortization (CF) has averaged $1.4 million across 5 years, with a median of $1.6 million in 2024.
  • Across the five-year window, Depreciation & Amortization (CF) tumbled 60.56% in 2025 and soared 74.72% in 2026, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $1.7 million in 2022, then decreased by 6.22% to $1.6 million in 2023, then tumbled by 59.05% to $661000.0 in 2024, then surged by 72.01% to $1.1 million in 2025, then declined by 3.34% to $1.1 million in 2026.
  • Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $803000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 41.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - 91,781.47
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Precigen 1.96 Bn 1.96 Bn 20.69 Mn 1.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.10 Mn
Mar 31, 2026 1.10 Mn
Dec 31, 2025 1.14 Mn
Dec 31, 2025 1.14 Mn
Sep 30, 2025 803,000.00
Sep 30, 2025 803,000.00
Jun 30, 2025 630,000.00
Jun 30, 2025 630,000.00
Mar 31, 2025 629,000.00
Mar 31, 2025 629,000.00
Dec 31, 2024 661,000.00
Dec 31, 2024 661,000.00
Sep 30, 2024 674,000.00
Sep 30, 2024 674,000.00
Jun 30, 2024 1.60 Mn
Jun 30, 2024 1.60 Mn
Mar 31, 2024 1.60 Mn
Mar 31, 2024 1.60 Mn
Dec 31, 2023 1.61 Mn
Dec 31, 2023 1.61 Mn